What is a stock summary page? Click here for an overview.
Business Description
Vytrus Biotech SA
ISIN : ES0105618005
Compare
Compare
Traded in other countries / regions
VYT.SpainV5P.Germany IPO Date
2022-03-15Description
Vytrus Biotech SA develops natural active ingredients on an industrial scale. The natural actives offered by the company include Nectaria Lithops, Olea Vitae, Turmeric zen, Capilia Longa, Qura Noni.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.82 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.4 | |||||
| Debt-to-EBITDA | 1.89 | |||||
| Interest Coverage | 5.46 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.15 | |||||
| Beneish M-Score | -2.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 32.2 | |||||
| 3-Year EBITDA Growth Rate | 27.2 | |||||
| 3-Year EPS without NRI Growth Rate | 46.1 | |||||
| 3-Year Book Growth Rate | 15.7 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.79 | |||||
| 9-Day RSI | 69.14 | |||||
| 14-Day RSI | 69.61 | |||||
| 3-1 Month Momentum % | 23.15 | |||||
| 6-1 Month Momentum % | 20.91 | |||||
| 12-1 Month Momentum % | 18.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.28 | |||||
| Quick Ratio | 2.81 | |||||
| Cash Ratio | 2.06 | |||||
| Days Sales Outstanding | 53.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 1.8 | |||||
| Shareholder Yield % | -7.92 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 110.68 | |||||
| Operating Margin % | 15.93 | |||||
| Net Margin % | 16.26 | |||||
| FCF Margin % | 7.46 | |||||
| ROE % | 12.2 | |||||
| ROA % | 7.16 | |||||
| ROIC % | 10.91 | |||||
| 3-Year ROIIC % | 15.18 | |||||
| ROC (Joel Greenblatt) % | 45.74 | |||||
| ROCE % | 7.92 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 30.42 | |||||
| PE Ratio without NRI | 30.42 | |||||
| Price-to-Owner-Earnings | 74.87 | |||||
| PEG Ratio | 0.46 | |||||
| PS Ratio | 4.89 | |||||
| PB Ratio | 3.23 | |||||
| Price-to-Tangible-Book | 7.49 | |||||
| Price-to-Free-Cash-Flow | 62.13 | |||||
| Price-to-Operating-Cash-Flow | 14.82 | |||||
| EV-to-EBIT | 33.23 | |||||
| EV-to-EBITDA | 15.83 | |||||
| EV-to-Revenue | 5.32 | |||||
| EV-to-FCF | 71.23 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.44 | |||||
| Price-to-Graham-Number | 3.21 | |||||
| Earnings Yield (Greenblatt) % | 3.01 | |||||
| FCF Yield % | 1.44 | |||||
| Forward Rate of Return (Yacktman) % | 19.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vytrus Biotech SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 4.288 | ||
| EPS (TTM) (€) | 0.096 | ||
| Beta | 0.37 | ||
| 3-Year Sharpe Ratio | -0.23 | ||
| 3-Year Sortino Ratio | -0.38 | ||
| Volatility % | 24.67 | ||
| 14-Day RSI | 69.61 | ||
| 14-Day ATR (€) | 0.027164 | ||
| 20-Day SMA (€) | 2.861 | ||
| 12-1 Month Momentum % | 18.75 | ||
| 52-Week Range (€) | 2.1 - 2.92 | ||
| Shares Outstanding (Mil) | 7.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vytrus Biotech SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vytrus Biotech SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vytrus Biotech SA Frequently Asked Questions
What is Vytrus Biotech SA(XMAD:VYT)'s stock price today?
The current price of XMAD:VYT is €2.92. The 52 week high of XMAD:VYT is €2.92 and 52 week low is €2.10.
When is next earnings date of Vytrus Biotech SA(XMAD:VYT)?
The next earnings date of Vytrus Biotech SA(XMAD:VYT) is .
Does Vytrus Biotech SA(XMAD:VYT) pay dividends? If so, how much?
Vytrus Biotech SA(XMAD:VYT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers